QNBCs are an aggressive tumor subtype, as they have been identified to exhibit a basal-like molecular phenotype, including higher rates of TP53 mutations, to be highly proliferative, are diagnosed at a younger age, and are associated with a significantly shorter disease-free survival period, compared to TNBC [10,11,12,13,14]. Here, TP53 is linked to neoplasm.